German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 65091
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
65091
Date of registration
29.09.2014
Company name
GlaxoSmithKline AG
Revision date
Valid until
Indication
Date of market entry
Index Therapeuticus (BSV)
30000.
Revocation Date
Index Therapeuticus (Swissmedic)
03.04.30.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Incruse Ellipta
einzeldosiertes Pulver zur Inhalation
Inhalation Powder (Umeclidinium 62.5 µg)
R03BB07
CI
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
